You are hereBlogs / admin's blog / Emerging role of thiamine therapy for prevention and treatment of early stage diabetic nephropathy
Emerging role of thiamine therapy for prevention and treatment of early stage diabetic nephropathy
Rabbani N, Thornalley PJ. Emerging role of thiamine therapy for prevention and treatment of early stage diabetic nephropathy. Diabetes Obes Metab. 2011 Feb 22. doi: 10.1111/j.1463-1326.2011.01384.x. [Epub ahead of print] PubMed PMID: 21342411
Thiamine supplementation prevented the development of early-stage nephropathy in diabetic rats and reversed increased urinary albumin excretion in patients with type 2 diabetes and microalbuminuria in two recent clinical trials.
Access to Parenteral Thiamine
Biological Therapies supplies a range of registered injections containing parenteral thiamine.
See the TGA website: http://www.tga.gov.au/safety/alerts-medicine-ivthiamine-100728.htm
See also the SHPA website: SHPA Manufacturers Alerts (Thiamine Injection)


